Abstract
Clinical observations show that two subtypes of sinonasal malignant melanoma exist: uni- and multilocular melanoma. The aim of this retrospective study was to determine the prevalence and outcome of multilocular sinonasal malignant melanoma. All patients with sinonasal malignant melanoma treated at our institution between 1992 and 2011 were included. Survival and recurrence data were analyzed related to the distribution pattern of the tumors and other factors. Twenty-five patients were identified and included in the analysis. Seven patients (28 %) suffered from multilocular, the remaining 18 patients (72 %) from unilocular sinonasal malignant melanoma. The first group showed a significantly worse disease-free survival, whereas disease-specific and overall survival did not differ between the two subtypes. Multilocular sinonasal malignant melanoma is associated with an unfavorable disease-free survival compared to its unilocular counterpart.
Similar content being viewed by others
References
Lund VJ, Howard DJ, Harding L, Wei WI (1999) Management options and survival in malignant melanoma of the sinonasal mucosa. Laryngoscope 109:208–211
Lund VJ, Chisholm EJ, Howard DJ, Wei WI (2012) Sinonasal malignant melanoma: an analysis of 115 cases assessing outcomes of surgery, postoperative radiotherapy and endoscopic resection. Rhinology 50:203–210
Bachar G, Loh KS, O’Sullivan B, Goldstein D, Wood S, Brown D et al (2008) Mucosal melanomas of the head and neck: experience of the Princess Margaret Hospital. Head Neck 30:1325–1331
Keller DS, Thomay AA, Gaughan J, Olszanski A, Wu H, Berger AC et al (2013) Outcomes in patients with mucosal melanomas. J Surg Oncol. doi:10.1002/jso.23445
Roth TN, Gengler C, Huber GF, Holzmann D (2010) Outcome of sinonasal melanoma: clinical experience and review of the literature. Head Neck 32:1385–1392
Mendenhall WM, Amdur RJ, Hinerman RW, Werning JW, Villaret DB, Mendenhall NP (2005) Head and neck mucosal melanoma. Am J Clin Oncol 28:626–630
Kingston NJ, Jones RW, Baranyai J (2004) Recurrent primary vulvovaginal malignant melanoma arising in melanoma in situ—the natural history of lesions followed for 23 years. Int J Gynecol Cancer 14:628–632
Lotem M, Anteby S, Peretz T, Ingber A, Avinoach I, Prus D (2003) Mucosal melanoma of the female genital tract is a multifocal disorder. Gynecol Oncol 88:45–50
Moreno MA, Roberts DB, Kupferman ME, DeMonte F, El-Naggar AK, Williams M et al (2010) Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M. D. Anderson Cancer Center. Cancer 116:2215–2223
Krengli M, Jereczek-Fossa BA, Kaanders JH, Masini L, Beldì D, Orecchia R (2008) What is the role of radiotherapy in the treatment of mucosal melanoma of the head and neck? Crit Rev Oncol Hematol 65:121–128
Owens JM, Roberts DB, Myers JN (2003) The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region. Arch Otolaryngol Head Neck Surg 129:864–868
Bridger AG, Smee D, Baldwin MA, Kwok B, Bridger GP (2005) Experience with mucosal melanoma of the nose and paranasal sinuses. ANZ J Surg 75:192–197
Temam S, Mamelle G, Marandas P, Wibault P, Avril MF, Janot F et al (2005) Postoperative radiotherapy for primary mucosal melanoma of the head and neck. Cancer 103:313–319
Patel SG, Prasad ML, Escrig M, Singh B, Shaha AR, Kraus DH et al (2002) Primary mucosal malignant melanoma of the head and neck. Head Neck 24:247–257
Dauer EH, Lewis JE, Rohlinger AL, Weaver AL, Olsen KD (2008) Sinonasal melanoma: a clinicopathologic review of 61 cases. Otolaryngol Head Neck Surg 138:347–352
Prasad ML, Busam KJ, Patel SG, Hoshaw-Woodard S, Shah JP, Huvos AG (2003) Clinicopathologic differences in malignant melanoma arising in oral squamous and sinonasal respiratory mucosa of the upper aerodigestive tract. Arch Pathol Lab Med 127:997–1002
Koivunen P, Bäck L, Pukkila M, Laranne J, Kinnunen I, Grénman R et al (2012) Accuracy of the current TNM classification in predicting survival in patients with sinonasal mucosal melanoma. Laryngoscope 122:1734–1738
Thompson LD, Wieneke JA, Miettinen M (2003) Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol 27:594–611
Liao JJ, Parvathaneni U, Laramore GE, Thompson JA, Bhatia S, Futran ND et al (2013) Fast neutron radiotherapy for primary mucosal melanomas of the head and neck. Head Neck. doi:10.1002/hed.23428
Haerle SK, Soyka MB, Fischer DR, Murer K, Strobel K, Huber GF et al (2012) The value of 18F-FDG-PET/CT imaging for sinonasal malignant melanoma. Eur Arch Otorhinolaryngol 269:127–133
Cohen Y, Rosenbaum E, Begum S, Goldenberg D, Esche C, Lavie O et al (2004) Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites. Clin Cancer Res 10:3444–3447
Curtin JA, Busam K, Pinkel D, Bastian BC (2006) Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 24:4340–4346
Went PT, Dirnhofer S, Bundi M, Mirlacher M, Schraml P, Mangialaio S et al (2004) Prevalence of KIT expression in human tumors. J Clin Oncol 22:4514–4522
Hersey P, Bastholt L, Chiarion-Sileni V, Cinat G, Dummer R, Eggermont AM et al (2009) Small molecules and targeted therapies in distant metastatic disease. Ann Oncol 20(Suppl 6):vi35–vi40
Ugurel S, Hildenbrand R, Zimpfer A, La Rosée P, Paschka P, Sucker A et al (2005) Lack of clinical efficacy of imatinib in metastatic melanoma. Br J Cancer 92:1398–1405
Wyman K, Atkins MB, Prieto V, Eton O, McDermott DF, Hubbard F et al (2006) Multicenter phase II trial of high-dose imatinib mesylate in metastatic melanoma: significant toxicity with no clinical efficacy. Cancer 106:2005–2011
Satzger I, Küttler U, Völker B, Schenck F, Kapp A, Gutzmer R (2010) Anal mucosal melanoma with KIT-activating mutation and response to imatinib therapy—case report and review of the literature. Dermatology 220:77–81
Mocellin S, Lens MB, Pasquali S, Pilati P, Chiarion Sileni V (2013) Interferon alpha for the adjuvant treatment of cutaneous melanoma. Cochrane Database Syst Rev. doi:10.1002/14651858.CD008955.pub2
Papaspyrou G, Garbe C, Schadendorf D, Werner JA, Hauschild A, Egberts F (2011) Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors. Melanoma Res 21:475–482
Gore MR, Zanation AM (2012) Survival in sinonasal melanoma: a meta-analysis. J Neurol Surg B Skull Base 73:157–162
McLean N, Tighiouart M, Muller S (2008) Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma. Oral Oncol 44:1039–1046
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
O. Stanimirov Rossi and D. Vital contributed equally to this study.
Rights and permissions
About this article
Cite this article
Stanimirov Rossi, O., Vital, D., Soyka, M.B. et al. Multilocular sinonasal malignant melanoma: a poor prognostic subgroup?. Eur Arch Otorhinolaryngol 272, 123–129 (2015). https://doi.org/10.1007/s00405-014-3098-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-014-3098-z